Contact Information
Tel: +44 1789 451831
Fax: +44 1789 450682
Email: info@heartrhythmcongress.org.uk
Heart Rhythm Congress
PO Box 3697
HRC 2011 Programme
Presentations are available where the title and speaker are highlighted - click on the link to view. Please note: HRUK Certificate of Accreditation course presentations are only available to delegates who paid to attend these sessions.
Sunday 2nd October
ARRHYTHMIA ALLIANCE PATIENTS DAY
ATRIAL FIBRILLATION ASSOCIATION PATIENTS DAY
STARS PATIENTS DAY
HRUK CERTIFICATE OF ACCREDITATION COURSE: CORE
Monday 3rd October
A FOCUS ON ANTI-ARRHYTHMIC DRUGS: WHO RULES THE WAVES?
CLINICAL APPLICATION OF HOME MONITORING IN BRADYCARDIA DEVICES
DEVICE BASED STROKE PROPHYLAXIS, A PRACTICAL APPROACH TO HIGH RISK PATIENTS
DEVICES IN INHERITED CARDIAC CONDITIONS
DEVICE ISSUES IN HEART FAILURE AND HEART MUSCLE DISEASE
GENOME TO PRACTICE PRIMER
HANDS-ON SESSION
HEART RHYTHM TRAINEES
HRUK CERTIFICATE OF ACCREDITATION COURSE: DEVICES
INNOVATIVE THERAPIES TO ADVANCE PATIENT CARE
MODERATED POSTERS 1
ORAL ABSTRACTS 1
ORAL ANTICOAGULANTS IN AF: FROM RESEARCH TO PRACTICE
PAEDIATRIC EP
T-LoC/BLACKOUTS: A 360 DEGREE VIEWPOINT
Tuesday 4th October
A BRAVE NEW WORLD:WILL THE NHS REFORMS REALLY CHANGE THE LANDSCAPE?
ABLATION - STORIES FROM THE EXPERTS
ADVANCES IN QUALITY AND EFFICIENCY OF ARRHYTHMIA MANAGEMENT
ALLIED PROFESSIONALS
CHALLENGING DEVICE CASES
CONTROVERSIES WITH ICDS
DEVICE COMPLICATIONS: HOW TO DEAL WITH THEM
DIAGNOSING ICD AND PACEMAKER TRACES
EPIDEMIOLOGY AND CAUSATION OF ATRIAL FIBRILLATION
INNOVATION IN CARDIAC RHYTHM MANAGEMENT
LEFT SIDED SOLUTIONS - ATRIAL FIBRILLATION AND HEART FAILURE
MANAGEMENT OF INAPPROPRIATE SHOCKS IN ICD PATIENTS
MODERATED POSTERS 2
ORAL ANTICOAGULANTS ENTER THE DRAGONS' DEN
STRUCTURE AND FUNCTION OF THE ATRIA
T-LoC/BLACKOUTS: PROVIDING SERVICES
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (1)
YOUNG INVESTIGATORS COMPETITION
Wednesday 5th October
ANTIARRHYTHMIC THERAPY FOR ATRIAL FIBRILLATION
ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION
CASES AND TRACES
HRUK CERTIFICATE OF ACCREDITATION COURSE: ELECTROPHYSIOLOGY
ORAL ABSTRACTS 2
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (2)
WHAT TO DO WHEN THE BATTERY RUNS DOWN
ARRHYTHMIA ALLIANCE PATIENTS DAY - The National Patient Group Meeting: Living with, Treating and Managing Arrhythmias
Sunday 2nd October 2011 10:30 - 16:00
Salisbury
Information, Support and Advice
| Chair: | J Tagney | |
| 10:30 | Welcome | J Tagney |
| 10:40 |
How a patient group works for you | S Shunmoogum |
| 11:00 | What you can expect from A-A: Bridging the gap | C Holmes |
| 11:20 | Your guide to successful fundraising | W Adams |
| 11:40 | Defibrillators in the community | J Eden |
| 11:55 | Getting the most from your Arrhythmia Nurse | J Maloney |
| 12:15 | Question Time | |
| 12:30 | Lunch |
Your Questions Answered
| Chair: | W Adams | |
| 13:30 | Exercising with an Arrhythmia: Your questions answered | A Wolff |
| 13:50 | Dos and don'ts of travelling - Information for your Support Group | S Jones |
| 14:10 | Living with devices | J Tagney |
| 14:30 | Ask the expert panel of speakers | J Eden S Jones S Shunmoogum J Tagney A Wolff |
| 15:00 | Summing up and feedback | W Adams |
| 15:15 | Meet and chat | |
| 16:00 | Close |
ATRIAL FIBRILLATION ASSOCIATION PATIENTS DAY
Sunday 2nd October 2011 10:30 - 16:00
Churchill & Gladstone
Assessing the Risks & What Other Drugs Might I be Given?
| Chair: | A Wolff | |
| 10:30 |
Message of thanks from the AFA team | J Jerrome |
| 10:45 | Assessing risks > Anti arrhythmic drugs/beta blockers/why are they used?/side effects/ place in treatment pathway |
C Cowan |
| 11:15 | Stroke prevention in atrial fibrillation > What is anticoagulation? > Emerging treatment options (including devices), but which is for me and will I be automatically offered any of these new options? |
M Earley |
Other Options for Treating AF
| Chair: | A Wolff |
|
| 11:45 | When is catheter ablation an option? | G Thomas |
| 12:05 | What is minimally invasive surgical ablation and who might be suitable for this? |
J Hyde |
| 12:25 | Pace and ablate: the risks and the benefits | J Pitts-Crick |
| 12:45 | Lunch |
AF and You
| Chair: | J Maloney | |
| 13:45 | I am healthy but I have AF, what lifestyle changes can I make to help? | M Fay |
| 14:15 | I feel so lonely, are there any support services which could help? | J Maloney |
Discussion
| Chair: | M Fay | |
| In the new commissioning of NHS services, where will AF be managed and what is my entitlement to accessing specialist AF? |
||
| 14:45 | Redress unwarranted inequalities in access - The Role of Commissioning | J Howell |
| 15:05 | What does a successful model of care look like? | D Bruce |
| 15:20 | AF in Primary Care | C Arden |
| 15:40 | Specialists in AF - timely referrals to improve outcomes | M O'Neill |
| 16:00 | Close |
STARS PATIENTS DAY
Sunday 2nd October 2011 10:00 - 15:45
Terrace
Diagnosis
| Chair: | B Karabin | |
| 10:00 | How to communicate with your GP | M Fay |
| 10:30 |
Use of ILRs, how they are implanted, after care | N Linker |
| 11:00 | Break |
Syncope Affects All Ages
| Chair: | J Cozon | |
| 11:10 | Growing up with RAS - crossing over from childhood to adolescence | W Whitehouse |
| 11:35 | My experience of syncope at 17 years | K Kavi |
| 11:45 | Syncope we grow older | L Kavi |
| 12:05 | POTS and Syncope: How I manage work and my recent experience of pregnancy |
A Kiernan |
| 12:30 | Lunch |
Syncope Treatment and Support
| Chair: | T Lobban | |
| 13:30 | When is it time to consider a pacemaker in a child? |
K McLeod |
| 14:00 | POTS - diagnosis and treatment options |
G Thomas |
| 14:15 | POTS and Syncope: Understanding why people faint and what can be done about it |
B Karabin |
| 15:00 | Question Time | |
| 15:30 | Message of thanks from the STARS team | T Lobban |
| 15:45 | Close |
HRUK CERTIFICATE OF ACCREDITATION COURSE: CORE
Sunday 2nd October 2011 13:00 - 17:15
Arden
| Chair: | N Linker |
|
| 13:00 | Exam overview | N Linker |
| 13:15 | "Electrical" anatomy of the heart | D Begley |
| 13:50 | Arrhythmia mechanisms | N Davidson |
| 14:25 | Introduction to electrophysiology |
K Bain |
| 15:00 | Tea / Coffee | |
| Chair: | S Allen | |
| 15:30 | Drugs and the heart | N Linker |
| 16:05 | Clinical trials in arrhythmia management |
S Allen |
| 16:40 | Introduction to cardiac device function and troubleshooting | A Turley |
| 17:15 | Close |
A FOCUS ON ANTI-ARRHYTHMIC DRUGS: WHO RULES THE WAVES? (Sponsored by sanofi)
Monday 3rd October 2011 08:30 - 12:15
Salisbury & Wellington
A Look at the Role of Anti-arrhythmic Drugs in the Treatment of Atrial Fibrillation, with a Specific Focus on Guidelines and Patient Types
| Chair: | N Peters | |
| 08:30 | Introduction by the Chair | |
| 08:40 | How do the current anti-arrhythmic drugs compare? | N Sulke |
| 08:55 | What do the current guidelines tell us? | N Peters |
| 09:10 | Case studies of typical AF patients > The role of the cardiologist > The role of the electrophysiologist |
A Bakhai K Rajappan |
| 09:30 | Panel discussion | |
| 10:00 | Tea / Coffee |
Maximising the Benefits of Anti-arrhythmic Drugs: A Discussion around the Care Pathway and Guidance on when to introduce an Anti-arrhythmic Drug into the Patient Treatment Plan
| Chair: |
A J Camm | |
| 10:45 | Introduction by the Chair |
|
| 10:50 | Models of care in AF - do we know what we're doing? |
K Khan |
| 11:05 | Models of care in AF - hospital based services | A Bakhai |
| 11:20 | To anticoagulate or not to anticoagulate, in patients who need an AAD | M Fay |
| 11:35 | Multidisciplinary Masterclass > I would use an AAD in these patients > I would not use an AAD in these patients Discussion/ Q & A |
A J Camm & Panel |
| 12:15 | Close |
CLINICAL APPLICATION OF HOME MONITORING
IN BRADYCARDIA DEVICES (Sponsored by Biotronik)
Monday 3rd October 2011 08:30 - 12:15
Oxford
| Chair: | D Fluck & R Kaba |
|
| 08:30 | Experience and outcomes of Home Monitoring in pacemakers | D Fluck |
| 09:00 | Added benefits of Home Monitoring for bradycardia devices - what's in it for the electrophysiologist? |
E Rowland |
| 09:30 | Comparing the utility of Home Monitoring for bradycardia and tachycardia devices |
J Wright |
| 10:00 | Tea / Coffee | |
| 10:45 | Use of Home Monitoring technology in specific circumstances - case studies |
A M Choy |
| 11:10 | Understanding the optimal application of Home Monitoring in the day to day clinical setting |
S Allen |
| 11:30 | Troubleshooting pacemakers remotely - case studies | P Foley |
| 11:50 | Monitoring your patient, not device malfunctions, the true benefits of Home Monitoring |
I Clement |
| 12:15 | Close |
DEVICE BASED STROKE PROPHYLAXIS, A PRACTICAL APPROACH TO HIGH RISK PATIENTS (Supported by an educational grant from AGA Medical)
Monday 3rd October 2011 13:30 - 17:15
Oxford
| Chair: |
A J Camm, J Morgan & R Schilling |
|
| 13:30 | Introduction | R Schilling |
| 13:35 | Anatomy of the Left Atrium and it's role for thromboembolic events | A Cook |
| 14:00 | Imaging of the LAA and device placement |
J Newton |
| 14:25 | New drugs, new trials - how does LAA occlusion fit? | D Begley |
| 14:50 | Panel Discussion | |
| 15:00 | Tea/Coffee |
|
| 15:45 | The new factor with increased pressure in health care spending; how to gain funding for this procedure | E Rowland |
| 16:00 | Device based alternative for stroke prophylaxis, Case 1 | P Kanagaratnam |
| 16:20 | Device based alternative for stroke prophylaxis, Case 2 |
M Earley |
| 16:40 | Device based alternative for stroke prophylaxis, Case 3 |
J Morgan |
| 17:00 | Panel Discussion | |
| 17:10 | Summary | A J Camm |
| 17:15 | Close |
DEVICES IN INHERITED CARDIAC CONDITIONS
Monday 3rd October 2011 15:45 - 17:15
Cambridge
| Chair: |
C Garratt | |
| 15:45 | Hypertrophic cardiomyopathy | P Elliott |
| 16:10 | ARVC | P Lambiase |
| 16:30 | Long QT syndrome | E Behr |
| 16:55 | Brugada Syndrome | D Connelly |
| 17:15 | Close |
DEVICE ISSUES IN HEART FAILURE & HEART MUSCLE DISEASE
Monday 3rd October 2011 13:30 - 15:00
Cambridge
| Chair: |
M O'Neill | |
| 13:30 | Treatment to suppress ventricular ectopy in heart failure | D Begley |
| 14:00 | Device and ablation therapy in myptonic dystrophy, sarcoid, amyloid etc > Cardiomyopathy & Devices > Intervention |
J Bourke K Rajappan |
| 14:30 | What have we learnt from CRT trials in mild heart failure? |
M Gold |
| 15:00 | Close |
GENOME TO PRACTICE PRIMER
Monday 3rd October 2011 08:30 - 12:15
Cambridge
Monogenic Diseases: Mechanisms and Models
| Chair: | A Grace & P Lambiase |
|
| 08:30 | Inherited Cardiomyopathies | H Ashrafian |
| 09:00 | Ion channel disease | E Behr |
| 09:30 | Stem cell-based disease models |
H Ayetey |
| 10:00 | Tea / Coffee |
Complex Diseases: Genes and Function
| Chair: | H Ashrafian & N Peters | |
| 10:45 | Genetics of Atrial Fibrillation | P Ellinor |
| 11:15 | Arrhythmogenic molecular and structural remodelling |
M Boyett |
| 11:45 | Genetics and Sudden Death in Heart Failure | A Grace |
| 12:15 | Close |
HANDS-ON SESSION
Monday 3rd October 2011 13:30 - 17:15
Arden
Come and view the latest advances from Biotronik, Boston Scientific, Medtronic, Sorin & St Jude Medical
HEART RHYTHM TRAINEES - "HOW TO..."
Monday 3rd October 2011 17:30 - 19:00
Oxford
| Chair: | A Opel |
|
| 17:30 | How to write a grant and get it accepted | A Tinker |
| 17:45 |
How to write an abstract and get it accepted |
N Peters |
| 18:05 |
How to review a paper for a journal | I Savelieva |
| 18:20 | How to be a better presenter and tackle difficult questions | A J Camm |
| 18:40 | How to be a better leader | R Schilling |
| 19:00 | Close |
HRUK CERTIFICATE OF ACCREDITATION COURSE: DEVICES
Monday 3rd October 2011 08:30 - 12:15
Arden
| Chair: | C Regan |
|
| 08:30 | Implanting devices - a practical guide | S Harris |
| 09:00 | The physics of implantable devices |
M James |
| 09:30 | Pacemaker troubleshooting | C Regan |
| 10:00 | Tea/Coffee |
|
| Chair: | K Lascelles | |
| 10:45 | ICD troubleshooting | C Joyce |
| 11:15 | CRT troubleshooting |
K Lascelles |
| 11:45 | Recalls and faults - how to deal with them |
M Squirrell |
| 12:15 | Close |
INNOVATIVE THERAPIES TO ADVANCE PATIENT CARE (Sponsored by St Jude Medical)
Monday 3rd October 2011 13:30 - 17:15
Salisbury & Wellington
CRM Session
| Chair: |
C A Rinaldi |
|
| 13:30 | CRT Challenges - Greater Efficiency and Optimal Response | C A Rinaldi |
| 14:00 | MRI - Patient Benefits of 4w/Kg (Max Power Scanning) | M Schmitt |
| 14:30 | Implantable Monitors for Heart Failure - The Preferred Tool? |
T Betts |
| 15:00 | Tea / Coffee |
EP Session
| Chair: |
P Della Bella | |
| 15:45 | Innovation in Ablation Technology - Saving you Time and Improving Patient Outcomes |
P Della Bella |
| 16:15 | VT Consensus Document - What is it? What does it mean for your practice? |
S Murray |
| 16:45 | Fluoroscopy Time in Ablation - Minimsing the Risk | A Chow |
| 17:15 | Close |
MODERATED POSTERS 1
Monday 3rd October 2011 12:45 - 13:15
Monarch Suite Foyer
Abstract Numbers 31 - 38
| Chair: |
C Pepper & K Rajappan | |
| 31 | High Rate of Appropriate Therapy Justifies ICD Use in Elderly Patients | W Nicolson |
| 32 | First Experience of a New Remote Catheter System for Ablation of Atrial Fibrillation Using 3D Mapping Systems |
P Brown |
| 33 | Mitral Isthmus Ablation is Feasible, Effacious and Safe Using Robotic Remote Navigation System |
K Wong |
| 34 | Persistent Atrial Fibrillation Guided by Selective Continuous Activity Mapping: Towards more Effective Targeting of Fractionated Sites |
PB Lim |
| 35 | Complex Cardiac Device Implantation in a Large District General Hospital - Can it be done well? |
LTM Yung |
| 36 | Cost Analysis of Early Cardiac Device Infections | B Saberwal |
| 37 | Patient Satisfaction with Nurse-Led Follow Up Service for Atrial Fibrillation facilitated by Implantable Reveal XT Devices |
M Castro |
| 38 | Should Persistent Atrial Fibrillation always be Managed in Secondary Care? A Comparative Study of Current Practice |
A Jordan |
| 13:15 | Close |
ORAL ABSTRACTS 1
Monday 3rd October 2011 13:30 - 17:15
London
Atrial Fibrillation
| Chair: |
N Peters |
|
| 13:30 | The Use of Oral Anti-coagulants in the Management of Atrial Fibrillation. National Data from GRASP-AF |
C Cowan |
| 13:45 |
The Increasing Burden of Atrial Fibrillation on Healthcare in Scotland | AM Choy |
| 14:00 |
A Randomised Controlled Trial of Catheter Ablation vs. Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) |
R Hunter |
| 14:15 | A Randomised Trial of Cyroablation vs. Radiofrequency Ablation vs. Both for Paroxysmal AF |
E Duncan |
| 14:30 | Does Catheter Ablation of Atrial Fibrillation Reduce Risk of Stroke and Death? | R Hunter |
| 14:45 | Ablation for Atrial Fibrillation - The Impact of Repeat Procedures - 10 Years of Single Centre Experience |
P Brown |
| 15:00 | Tea / Coffee |
Cardiovascular Implantable Electronic Devices
| Chair: |
J Bourke | |
| 15:45 | High Rate of Appropriate ICD Therapy in Dilated Cardiomyopathy in UK Clinical Practice |
W Nicolson |
| 16:00 |
An Atrial Lead does not Lower the Inappropriate ICD Therapy Rate in Patients with AF |
W Nicolson |
| 16:15 |
Single Centre Experience of MR-Conditional Pacemaker Leads: No Difference in Complication Rates and Procedure Times Compared With Use of Standard Leads |
S Little |
| 16:30 | Cardiac Implantable Electronic Device Infection may be Successfully Managed with a Reburial Strategy in Selected Patients |
M Das |
| 16:45 | Survey of Antibiotic Prophylaxis for Implantable Cardiac Electronic Devices (ICED) Insertion |
E Lowe |
| 17:00 | Percutaneous Lead Extraction in Octogenarians | S Williams |
| 17:15 | Close |
ORAL ANTICOAGULANTS IN AF: FROM RESEARCH TO PRACTICE (Supported by NHS Improvement)
Monday 3rd October 2011 08:30 - 12:15
London
What is the Evidence?
| Chair: | C Cowan | |
| 08:30 | Introduction | C Cowan |
| 08:35 |
Stroke risk and AF: The evolving national picture | M Fay |
| 09:15 | AF, a silent epidemic? How to find the missing quarter | A Wolff |
| 10:00 | Tea/Coffee |
Evidence in Practice
| Chair: |
R Healicon | |
| 10:45 | Oral anticoagulant protocols in practice: The Greater Manchester approach to the introduction of new anticoagulation therapies |
A Fitchet J Ratcliffe |
| 11:05 | Contraindications to oral anticoagulation | M Smith |
| 11:25 | The importance of time in therapeutic range | C Cowan |
| 11:50 | The changing face of anticoagulation, medication and service provision | R MacLean |
| 12:15 | Close |
PAEDIATRIC EP
Monday 3rd October 2011 08:30 - 12:15
Churchill & Gladstone
| Chair: |
J Till & O Uzun |
|
| 08:30 | Recreational drugs and arrhythmias in younger children | A Ghuran |
| 09:15 | Home telemetry for children with pacemakers and AICDs - Benefits and limitations |
J McComb |
| 10:00 | Tea/Coffee |
|
| Chair: | A Duke & J Skinner | |
| 10:45 | New modalities for mapping incisional tachycardias following surgery for congenital heart disease |
M Lowe |
| 11:30 | Ablation in infants: indications, limitations, challenges and results |
E Rosenthal |
| 12:15 | Close |
T-LoC/BLACKOUTS: A 360 DEGREE VIEWPOINT
(Sponsored by STARS)
Monday 3rd October 2011 13:30 - 17:15
Churchill & Gladstone
| Chair: |
A Fitzpatrick |
|
| 13:30 | Can I deal with it here? The view from General Practice | M Fay |
| 14:00 | Can this one go home or stay in? The view from Casualty | C Mann |
| 14:30 | Is it in the Heart? The view from Cardiology |
N Gall |
| 15:00 | Tea / Coffee | |
| Chair: | J Bayliss | |
| 15:45 | Is it in the Autonomic System? The view from an Autonomic Disorders Clinic | B Karabin |
| 16:10 | Is it in the Head? The view from Neurology |
T Von Oertzen |
| 16:35 | Is it in the Age? The view from Elderly Care | E Brierley |
| 17:00 | Round Table Discussion - Questions & Answers | |
| 17:15 | Close |
A BRAVE NEW WORLD: WILL THE NHS REFORMS REALLY CHANGE THE LANDSCAPE? (Sponsored by PCCS)
Tuesday 4th October 2011 08:30 - 17:15
London
Atrial Fibrillation in the Post White Paper World
| Chair: |
K Griffith | |
| 08:30 | The role of the third sector | J Jerrome |
| 09:00 |
The role of the professional organisations | K Griffith |
| 09:30 | NHS Structures: Heart and Stroke Networks | P Mercer |
| 10:00 | Tea/Coffee |
Arrhythmia Services in the Post White Paper World
| Chair: |
M Fay | |
| 10:45 | New anticoagulants in a time of austerity | M Bull |
| 11:15 | 'No decision about me without me' | M Ellis |
| 11:45 | New structures and organisations | S Hepplewhite |
| 12:15 | Lunch |
Syncope in the Post White Paper World
| Chair: | A Wolff | |
| 13:30 | NICE and T-LoC |
N Gall |
| 14:00 | The perspective of the patient |
A Morris |
| 14:30 | The T-LoC clinic - value for money? | A Fitzpatrick |
| 15:00 | Tea/Coffee |
The Big Quiz Rematch
| Chair: |
H Purcell | |
| 15:45 | The teams from last year's 'Big Quiz' will once again be pitted against each other - one side being the GPwSIs and the other cardiologists from secondary and tertiary care. | |
| Team 1 - GPwSI | C Arden D Fitzmaurice K Griffith |
|
| Team 2 - Consultants | B Brown L Graham A Zaidi |
|
| 17:15 | Close |
|
ABLATION - STORIES FROM THE EXPERTS
Tuesday 4th October 2011 10:45 - 12:15
Lancaster
| Chair: |
S Furniss | |
| 10:45 | An AF ablation complication | J Bourke |
| 11:15 | AF ablation - pre-recorded case (Biosense Webster) | R Schilling |
| 11:45 | A challenging VT case with a complication - How I managed it | P Della Bella |
| 12:15 | Close |
ADVANCES IN QUALITY AND EFFICIENCY OF ARRHYTHMIA MANAGEMENT
(Sponsored by Medtronic)
Tuesday 4th October 2011 08:30 - 12:15
Cambridge
| Chair: |
R Schilling |
|
| 08:30 | Latest experience in reducing shocks - what is the impact? | M Sopher |
| 09:00 | Lean and mean...how to streamline your remote follow up service | A Zaidi |
| 09:30 | Remote monitoring - The era of data | R Gough |
| 10:00 | Tea / Coffee | |
| Chair: | M Sopher | |
| 10:45 | A randomized trial of Cyroablation vs. Radiofrequency Ablation vs. both for PAF: Results to date |
R Schilling |
| 11:15 | EU phased RF experience: what we have learned and what we need to know next |
S Murray |
| 11:45 | Innovative use of Reveal XT in Cryptogenic stroke patients | M Belham |
| 12:15 | Close |
ALLIED PROFESSIONALS
Tuesday 4th October 2011 08:30 - 17:15
Salisbury & Wellington
| Chair: |
J Upright | |
| 08:30 | An overview of last year's trials and what do they mean for CRM? | J de Bono |
| 09:00 | Antithrombotic treatment in AF, with a focus on the ESC & ACC/AHA guidelines | N Gall |
| 09:30 | Advancements in medicine - an overview | K Rajappan |
| 10:00 | Tea/Coffee | |
| Chair: | A Griffiths | |
| 10:45 | What's new in implants? | S Allen |
| 11:15 | Device case studies | S Allen |
| 12:15 | Lunch | |
| Chair: | S Allen | |
| 13:30 | Implantable loop recorders - Current controversies | J Upright |
| 13:50 | An inter-professional approach to VT ablation | I Wright |
| 14:10 | Supporting the device patient, from the allied health professionals perspective | S Jones |
| 14:30 | Brugada syndrome, where are we now? | P Lambiase |
| 15:00 | Tea / Coffee | |
| 15:45 | Allied Professionals Meeting - Arrhythmia Nurses |
|
| Chair: | A Griffiths, J Maloney | |
| 15:45 | Allied Professionals Meeting - Cardiac Physiologists | |
| Chair: | S Jones, C Joyce | |
| 17:15 | Close |
CHALLENGING DEVICE CASES
Tuesday 4th October 2011 15:45 - 17:15
Churchill & Gladstone
| Chair: |
D Connelly | |
| 15:45 | ICD implant | M Dayer |
| 16:15 | Lead extraction | C A Rinaldi |
| 16:45 | CRT implant | A Rao |
| 17:15 | Close |
CONTROVERSIES WITH ICDS
Tuesday 4th October 2011 13:30 - 15:00
Lancaster
| Chair: |
M Hall | |
| 13:30 | Dual chamber versus single chamber? | M Mason |
| 14:00 | Should we do DFT tests for primary prevention implants? | N Davidson |
| 14:30 | How to manage the faulty ICD lead | A Zaidi |
| 15:00 | Close |
DEVICE COMPLICATIONS: HOW TO DEAL WITH THEM
Tuesday 4th October 2011 13:30 - 15:00
Churchill & Gladstone
| Chair: |
M Gammage | |
| 13:30 | HRUK competencies statement for implantable cardiac devices - what are the implications? |
C Plummer |
| 14:00 | Implantation procedure - antibiotics? Sutures? Ioban? Collatamp? Rifampicin mesh? |
J Wright |
| 14:30 | Bridging therapy/antiplatelets (i.v. heparin, LMWH, dual antiplatelets) | A Rao |
| 15:00 | Close |
DIAGNOSING ICD AND PACEMAKER TRACES
Tuesday 4th October 2011 08:30 - 10:00
Lancaster
| Chair: |
S Jones | |
| 08:30 | Pacemaker cases | M Mason |
| 09:00 | ICD cases from Liverpool | D Todd |
| 09:30 | ICD cases from a DGH centre | J Timperley |
| 10:00 | Close |
EPIDEMIOLOGY AND CAUSATION OF ATRIAL FIBRILLATION (Sponsored by AFA)
Tuesday 4th October 2011 15:45 - 17:15
Arden
| Chair: |
P Ellinor & A Grace | |
| 15:45 | Introduction | |
| 15:50 | Genetic Basis for Atrial Fibrillation | P Kirchhof |
| 16:15 | Electrophysiological Determinants of Atrial Fibrillation | A Grace |
| 16:45 | Clinical Causes, Associations and Risks of Atrial Fibrillation | I Savelieva |
| 17:10 | Summary | |
| 17:15 | Close |
INNOVATION IN CARDIAC RHYTHM MANAGEMENT
Tuesday 4th October 2011 10:45 - 12:15
Oxford
| Chair: |
J McComb | |
| 10:45 | Screening for pacing indication in primary care; how to do it | C Plummer |
| 11:15 | AF and heart failure - AF ablation or Bi-V with AV node ablation? | M O'Neill |
| 11:45 | Strategies for minimizing ICD shocks | M Gold |
| 12:15 | Close |
LEFT SIDED SOLUTIONS - ATRIAL FIBRILLATION AND HEART FAILURE (Sponsored by Boston Scientific)
Tuesday 4th October 2011 13:30 - 17:15
Cambridge
| Chair: |
J Foran |
|
| 13:30 | LAAO - The Data, The Device and Starting a Service | T Betts M Buch |
| Talks and case presentation about LAA Occlusion > The history of LAAO and the clinical data > The Watchman device, case presentations and tips and tricks > Setting up an LAAO service (finding patients and securing funding) |
||
| 15:00 | Tea / Coffee | |
| Chair: | H Klein | |
| 15:45 | Life after MADIT-CRT | P Lambiase M McIntyre J Wright |
| 16:05 | Round table discussion on: How best to "capture" (identify, refer) the appropriate patients > Primary lessons from MADIT-CRT (and REVERSE and RAFT) > New insights from the sub-studies > Health Economics considerations of Guideline revision |
|
| 17:15 | Close |
MANAGEMENT OF INAPPROPRIATE SHOCKS IN ICD PATIENTS
Tuesday 4th October 2011 08:30 - 10:00
Oxford
| Chair: |
N Linker | |
| 08:30 | Atrial fibrillation | T Betts |
| 09:00 | SVT | A Morley-Davies |
| 09:30 | Non arrhythmic causes, recognitition and management | D Connelly |
| 10:00 | Close |
MODERATED POSTERS 2
Tuesday 4th October 2011 12:45 - 13:15
Monarch Suite Foyer
Abstract Numbers 39 - 46
| Chair: |
A Grace & A Rankin | |
| 39 | Long QT3 Mice have Disrupted Sympathovagal Balance and in Vivo Ventricular Stimulation does not determine Risk of Sudden Cardiac Death, Suggesting that a Second Perturbation to Increase Vagal Tone may be Critical |
A Opel |
| 40 | RGS 4 KO Mice are Predisposed to Atrial Fibrillation (AF) and Show Disrupted Sympathovagal Balance in Vivo, Making RGS 4 a Potential Novel Therapeutic Target for AF |
A Opel |
| 41 | Arrhythmic Burden in Families with Hypertrophic Cardiomyopathy related to Myosin Binding Protein C Mutations |
S Page |
| 42 | LV Pacing and the Difference in Acute Haemodynamic Response within Individual Branches of the Coronary Sinus |
A Shetty |
| 43 | Benefits of Endocardial and Multi-Site Pacing are dependent on the LV Electrical Activation Pattern and Presence of Ischaemic Heart Disease: Insights from Electro-anatomical Mapping |
M Ginks |
| 44 | The Electrophysiological Characteristics of Ventricular Arrhythmias and their relation to Cardiac Phenotype in Hypertrophic Cardiomyopathy |
C O'Mahony |
| 45 | Dynamic Conduction and Repolarisation Changes can help distinguish between Arrhythmic Right Ventricular Cardiomyopathy and Benign Right Ventricular Outflow Tract Tachycardia |
M Finlay |
| 46 | Characteristics of Eligible Patients who are not referred for Cardiac Resynchronisation Therapy |
V Nayar |
| 13:15 | Close |
ORAL ANTICOAGULANTS (OACs) ENTER THE DRAGON'S DEN
(Sponsored by Boehringer Ingelheim)
Tuesday 4th October 2011 10:45 - 12:15
Arden
For more information on this session click here.
| Chair: |
S Lawley | |
| 10:45 | Dragons | A J Camm D Jenkinson |
| Entrepreneurs | S Jarvis I Menown |
|
| 12:15 | Close |
STRUCTURE AND FUNCTION OF THE ATRIA
(Sponsored by AFA)
Tuesday 4th October 2011 13:30 - 15:00
Arden
| Chair: |
C Garratt & E Rowland | |
| 13:30 | Introduction | |
| 13:35 | The Role of Specialist Commissioning | T Daniel J Howell |
| 14:00 | The Left Atrium and its Appendage - Is Echo the right tool? | J Newton |
| 14:30 | CMR assessment of Left Atrial Fibrosis | M O'Neill |
| 14:55 | Summary | |
| 15:00 | Close |
T-LoC/BLACKOUTS: PROVIDING SERVICES
(Sponsored by STARS)
Tuesday 4th October 2011 08:30 - 12:15
Churchill & Gladstone
| Chair: |
E Brierley |
|
| 08:30 | What do the statistics tell us about T-LoC burden and cost? | S Petkar |
| 09:00 | Rapid Triage: What are we trying to achieve? | A Fitzpatrick |
| 09:30 | Setting up a new Blackouts Clinic |
J Mudd |
| 10:00 | Tea / Coffee | |
| Chair: | N Linker | |
| 10:45 | Innovative syncope services at the University of Toledo | B Karabin |
| 11:10 | What do patients worry about? |
L Kavi |
| 11:35 | How does STARS support patients and families? | T Lobban |
| 12:00 | Discussion | |
| 12:15 | Close |
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (1)
Tuesday 4th October 2011 08:30 - 10:00
Arden
| Chair: |
C Pepper | |
| 08:30 | How to set up an ICD in patients with structural heart disease | I Wright |
| 09:00 | Ablation for ventricular tachycardia in ICD patients in the UK - first, second or third line? |
J Bourke |
| 09:30 | The place of VT ablation in ICD patients in the USA | P Kojodjojo |
| 10:00 | Close |
YOUNG INVESTIGATORS COMPETITION
Tuesday 4th October 2011 13:30 - 17:15
Oxford
| Judges: |
A Ng (Chair), P Ellinor, C Pepper, A Rankin | |
| 13:30 | Characterisation of Fractionated Atrial Electrograms Critical for Maintenance of AF: A Randomised Controlled Trial of Ablation Strategies (The CFAE AF Trial) |
R Hunter |
| 14:00 | Multipolar Left Ventricular Pacing to optimise Acute Haemodynamic Response to Cardiac Resynchronisation Therapy |
S Ahsan |
| 14:30 | Novel Restitution Gradient based Predictor of Ventricular Arrhythmias |
W Nicolson |
| 15:00 | Tea / Coffee | |
| 15:45 | Electrophysiological Abnormalities Precede Overt Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy due to Mutations in Desmoplakin |
J Gomes |
| 16:15 | Cardiac Contractility Modulation (CCM) decreases the Ventricular Fibrillation threshold in the Isolated Rabbit Heart through a Beta1-adrenoceptor Dependent Mechanism |
J Winter |
| 16:45 | The Funny Current can be used to create a Biological Pacemaker by Enhancement of the Pacing Rate of Subsidiary Pacemaker Tissue in a Model of Sick Sinus Syndrome, but the Effectiveness of Different HCN Isoforms Markedly Differs |
G Morris |
| 17:15 | Close |
ANTIARRHYTHMIC THERAPY FOR ATRIAL FIBRILLATION (Sponsored by AFA)
Wednesday 5th October 2011 11:15 - 12:45
Salisbury & Wellington
| Chair: |
S Ernst & A Rankin | |
| 11:15 | Introduction | |
| 11:20 | Cardioversion of Atrial Fibrillation - Electrical vs. pharmaceutical | A Rankin |
| 11:45 | Dronedarone and other antiarrhythmic possibilites | I Savelieva |
| 12:15 | Left atrial ablation - State of the art and what's to come | S Ernst |
| 12:40 | Summary | |
| 12:45 | Close |
ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION (Sponsored by AFA)
Wednesday 5th October 2011 09:00 - 10:30
Salisbury & Wellington
| Chair: |
A J Camm & D Fitzmaurice | |
| 09:00 | Introduction | |
| 09:05 | When and how to use Dabigatran and other new agents | S James |
| 09:30 | Triple therapy - Which three drugs and for how long? | J McComb |
| 10:00 | Does left atrial ablation or left atrial appendage occlusion obviate anticoagulation | F Murgatroyd |
| 10:25 | Summary | |
| 10:30 | Close |
CASES AND TRACES
Wednesday 5th October 2011 09:00 - 15:30
Churchill & Gladstone
| Chair: |
S Fynn & M Hall |
|
| 09:00 | ECG diagnosis of Broad Complex Tachycardia | D Rowlands |
| 09:30 |
Screening families for Inherited Cardiac Conditions...when to start and when to stop |
P Lambiase |
| 10:00 |
Pearls & pitfalls of EP manoeuvres |
O Segal |
| 10:30 |
Tea / Coffee |
Triumphs & Disasters 1
| Chair: |
S Fynn & M Hall |
|
| 11:15 | N Davidson | |
| J Paisey | ||
| 12:45 | Lunch |
Triumphs & Disasters 2
| Chair: |
S Fynn & M Hall |
|
| 14:00 | S Murray | |
| J de Bono | ||
| S Harris |
||
| 15:30 | Close |
HRUK CERTIFICATE OF ACCREDITATION COURSE: ELECTROPHYSIOLOGY
Wednesday 5th October 2011 09:00 - 12:45
Arden
| Chair: |
S Blackman | |
| 09:00 | AVNRT | S Blackman |
| 09:30 | WPW and other accessory pathways | N Grubb |
| 10:00 | Ventricular Tachycardia | C Pepper |
| 10.30 | Tea/Coffee | |
| Chair: | S James | |
| 11:15 | Atrial Fibrillation | S James |
| 11:45 | Atrial Flutter | M Wright |
| 12:15 | Modern day ablation techniques: an overview of mapping systems and ablation technologies |
I Wright |
| 12:45 | Close |
ORAL ABSTRACTS 2
Wednesday 5th October 2011 09:00 - 12:45
Cambridge
Clinical Arrhythmia Practice
| Chair: |
F Osman |
|
| 09:00 | The Impact of Specialist Nurse Arrhythmia Clinics: Streamlining and Enhancing Patient Services |
S Hackett |
| 09:15 |
Cost Efficacy Analysis of Current Family Screening Protocol following a Sudden Arrhythmic Death (SADS) |
L Nunn |
| 09:30 |
Cardiac Resynchronisation Therapy using the Radpad Radiation Shield at Implant significantly reduces Radiation Dose to the Implanting Physician |
M Jones |
| 09:45 | Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England between 2006 and 2009 |
C Righetti |
| 10:00 | Clinical Coding for Electrophysiology and Device Procedures: Why and how to make it better |
A Hogarth |
| 10:15 | Pan-Hypopituitarism presenting as Syncopal Long QT | J Lane |
| 10:30 | Tea / Coffee |
Basic Science and CRT
| Chair: |
C A Rinaldi | |
| 11:15 | Enhancement of Gap Junctional Coupling during Acute Myocardial Infarction reduces Late Post-Infarction susceptibility to Ventricular Arrhythmias |
FS Ng |
| 11:30 |
Electrical Restitution in Single Cells - Effects of Acetylcholine and Nitric Oxide Donors |
R Patel |
| 11:45 |
Haemodynamic Consequences of Targeted Single and Dual Site Right Ventricular Pacing in Adults with Congenital Heart Disease undergoing Surgical Pulmonary Valve Replacement |
C Plymen |
| 12:00 | AV Delay Optimisation of Cardiac Resynchronisation Therapy using Invasive Haemodynamic Measurements is insufficiently Reproducible to be Clinically Useful; Unless Multiple Replicate Measurements relative to a Reference AV Delay are taken |
Z Whinnett |
| 12:15 | Is Real-Time CMR Dyssynchrony a Useful Tool in Guiding LV Lead Placement during CRT? |
A Shetty |
| 12:30 | Adverse Response to Cardiac Resynchronisation Therapy in Patients with Septal Scar on Cardiac MRI preventing a Septal Right Ventricular Lead Position |
S Duckett |
| 12:45 | Close |
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (2)
Wednesday 5th October 2011 09:00 - 10:30
Oxford
| Chair: |
L Graham | |
| 09:00 | Ventricular tachycardia in structural heart disease - the basic science | C Garratt |
| 09:30 | Evidence based treatment for VT - does everyone need an ICD? | D Todd |
| 10:00 | Antiarrhythmic drug treatment at baseline or only after therapy? | C Plummer |
| 10:30 | Close |
WHAT TO DO WHEN THE BATTERY RUNS DOWN
Wednesday 5th October 2011 11:15 - 12:45
Oxford
| Chair: |
M Dayer | |
| 11:15 | Patients paced for sinus node disease, now in persistent AF | S Harris |
| 11:40 | Primary prevention ICD but no therapy delivered | M Dayer |
| 12:00 | CRT-D in a patient whose IV function has significantly improved | A Turley |
| 12:25 | CRT with no clinical benefit | P Foley |
| 12:45 | Close |
HOME


.png)




